Back to top
more

Encompass Health (EHC)

(Real Time Quote from BATS)

$103.80 USD

103.80
106,130

+0.27 (0.26%)

Updated Nov 8, 2024 12:01 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (51 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks News

CVS Health (CVS) Expands Food and Beverage Line With New Launch

CVS Health's (CVS) Well Market brand offers a blend of mouthwatering flavors and nutritious options, expertly crafted and taste-tested by food enthusiasts.

Encompass Health (EHC) Opens Rehabilitation Hospital in Ballwin

The 40-bed inpatient rehabilitation hospital is a JV between Encompass Health (EHC) and BJC HealthCare.

Elevance (ELV) Rises 14.9% YTD: What Lies Ahead for Investors?

Elevance (ELV) continues to focus on increasing shareholder value with consistent dividend payouts and stock repurchases.

Veracyte (VCYT) Up 6% Since Last Earnings: Will it Continue?

Investors are optimistic about Veracyte (VCYT) led by strength in the testing business and upbeat guidance.

Boston Scientific (BSX) mCRM System Study Outcome Favorable

Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.

Is Encompass Health (EHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid

Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.

Maravai (MRVI) Advances in RNA Research With New Collaboration

Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.

Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?

Investors are optimistic about Haemonetics (HAE) led by its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns.

Why Encompass Health (EHC) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why You Should Add Encompass Health (EHC) to Your Portfolio Now

Encompass Health (EHC) remains well-poised for growth on the back of robust demand for effective inpatient rehabilitation services, joint ventures and solid cash reserves.

Align Technology (ALGN) Gains From Innovation, Global Expansion

In the United States, Align Technology (ALGN) is focused on reaching young adults as well as teens and their parents through famous athletes, influencers and fashion designers.

Prestige Consumer (PBH) Q4 Earnings Miss, Operating Margin Falls

Prestige Consumer's (PBH) Q4 business suffers from supply chain pressure that impacts its ability to fulfill retailer orders.

Labcorp (LH) to Assess Preeclampsia Risk With New Test

Labcorp's (LH) new first-trimester test is the latest addition to its dedication to improving women's health.

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

Investors are optimistic about Henry Schein (HSIC), owing to strategic acquisitions and potential in Henry Schein One.

Here's Why You Should Buy Align Technology (ALGN) Stock Now

Investors are optimistic about Align Technology (ALGN) led by expansion in new geographies and upbeat guidance.

QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification

QIAGEN's (QGEN) Clinical Insight Interpret is the first NGS interpretation platform approved by IVDR for use in cancer and hereditary applications.

Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand

Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.

Here's Why You Should Retain Centene (CNC) Stock for Now

Centene (CNC) remains well-poised for growth on the back of sound growth in membership, divestitures and a growing cash balance.

Here's Why Encompass Health (EHC) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

QIAGEN (QGEN) to Enhance Forensics With New Partnership

QIAGEN's (QGEN) recent deal advances a novel test for its QIAcuity digital PCR devices. This will enhance forensics by improving the quantification of DNA in human samples.

Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised

Insulet's (PODD) first-quarter performance benefits from the continued high demand for Omnipod 5.

Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?

Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand

Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.

STERIS (STE) Q4 Earnings Match Estimates, Margins Contract

STERIS' (STE) fourth-quarter performance in AST is dented by a decline in capital equipment revenues. The contraction of margins is concerning.